SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Shanghai AoHua Photoelectricity Endoscope Co., Ltd. Share Price
Equities
688212
CNE100004ZJ5
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.4 CNY | -0.13% |
|
+5.93% | -10.69% |
| Sales 2024 * | 999M 138M 11.04B | Sales 2025 * | 1.43B 198M 15.83B | Capitalization | 7.43B 1.02B 82.07B |
|---|---|---|---|---|---|
| Net income 2024 * | 102M 14.08M 1.13B | Net income 2025 * | 174M 24.01M 1.92B | EV / Sales 2024 * | 7.43 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.18 x |
| P/E ratio 2024 * |
72.9
x | P/E ratio 2025 * |
42.8
x | Employees | 1,092 |
| Yield 2024 * |
0.18% | Yield 2025 * |
0.45% | Free-Float | 59.41% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.13% | ||
| 1 week | +5.93% | ||
| Current month | -8.49% | ||
| 1 month | -10.65% | ||
| 3 months | +8.37% | ||
| 6 months | -12.04% | ||
| Current year | -10.69% |
1 week
49.12
56.64
1 month
49.1261.57
Current year
46.0666.52
1 year
46.0674.33
3 years
32.0084.00
5 years
32.0084.00
10 years
32.0084.00
| Managers | Title | Age | Since |
|---|---|---|---|
Xiao Zhou Gu
CEO | Chief Executive Officer | 40 | 31/01/08 |
Jia Li Xu
CHM | Chairman | 34 | 30/09/15 |
Cheng Hao Qian
DFI | Director of Finance/CFO | 43 | 31/01/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wen Cai Pan
BRD | Director/Board Member | 47 | 23/04/20 |
Quan Zhou
BRD | Director/Board Member | 49 | 30/04/18 |
Cheng Hao Qian
DFI | Director of Finance/CFO | 43 | 31/01/13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 55.4 | -0.13% | 1,814,866 |
| 25/04/24 | 55.47 | +2.61% | 1,375,718 |
| 24/04/24 | 54.06 | +0.48% | 1,418,445 |
| 23/04/24 | 53.8 | +5.61% | 2,558,394 |
| 22/04/24 | 50.94 | -2.60% | 2,043,606 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Shanghai Aohua Photoelectricity Endoscope Co Ltd is a China-based company mainly engaged in the research and development of medical devices. The Company's main businesses are the research, development, production and sales of electronic endoscopic equipment and endoscopic diagnostic and surgical consumables. The Company's products include endoscopic equipment and endoscopic diagnostic and surgical consumables. The Company's products are mainly used in clinical departments such as gastroenterology, respiratory, ears, nose, and throat (ENT), gynecology, and emergency departments.
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
55.4
CNY
Average target price
71.08
CNY
Spread / Average Target
+28.31%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.69% | 1.02B | |
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -20.89% | 905M | |
| -7.14% | 716M | |
| -18.10% | 682M | |
| +4.01% | 480M |
- Stock Market
- Equities
- 688212 Stock
